Enanta Pharmaceuticals Inc (ENTA)

[NY1972]

ENTA longs are running away from the falling knives from the 4 mil. shares shorts who have a bigger interest in sh. price than BlackRock, Eagle and FMR combined. Until Luly throws some milestones at the falling knives, the bleeding continues.



ENTA -8% on no news. Evidently, investors are literally interpreting Rick Gonzalez’s guidance for 2016 V-Pak sales of $2B